| ADR Ontology |
| ADR Term |
Macular oedema |
| ADR ID |
BADD_A02633 |
| ADR Hierarchy |
|
| Description |
Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90) | Fluid accumulation in the outer layer of the MACULA LUTEA at the center of the RETINA in a petaloid pattern where cystic spaces are formed and may lead to macular depressions or holes. [MeSH] |
| MedDRA Code |
10025415 |
| MeSH ID |
D008269
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Macula lutea oedema | Macular oedema | Macula lutea edema | Macular edema | Macular focal oedema | Macular diffuse oedema | Macular focal edema | Macular diffuse edema | Macular swelling | Macular Edema | Edema, Macular | Irvine-Gass Syndrome | Irvine Gass Syndrome | Syndrome, Irvine-Gass | Cystoid Macular Edema, Postoperative | Macular Edema, Cystoid | Edema, Cystoid Macular | Cystoid Macular Dystrophy | Macular Dystrophy, Dominant Cystoid | Central Retinal Edema, Cystoid | Cystoid Macular Edema |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D02511 | Siponimod | 0.001326% | | | BADD_D02580 | Ozanimod | 0.000844% | |
| The 3th Page First
Pre
3
Total 3 Pages
|
|
